Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $32.9800 (0.09%) ($32.1100 - $33.1900) on Fri. Apr. 27, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.02% (three month average) | RSI | 56 | Latest Price | $32.9800(0.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.9% a day on average for past five trading days. | Weekly Trend | EDIT declines -2.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(62%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.01% in a week (0% probabilities). VIXM(-12%) TLT(-5%) SHY(-5%) GDXJ(-5%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.01% (StdDev 4.02%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $33.62 | 5 Day Moving Average | $32.71(0.83%) | 10 Day Moving Average | $33.77(-2.34%) | 20 Day Moving Average | $33.62(-1.9%) | To recent high | -25.2% | To recent low | 3.8% | Market Cap | $2.048b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |